Home › Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research
 

Keywords :   


Opexa Therapeutics Inc (OPXA) Upgraded to "Buy" by Zacks Investment Research

2016-01-25 01:16:11| Biotech - Topix.net

The firm presently has a $2.00 price target on the biopharmaceutical company's stock. Zacks Investment Research 's target price indicates a potential upside of 4.04% from the stock's current price.

Tags: buy research investment upgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Eastern North Pacific Tropical Weather Outlook
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
More »